Notice of Meeting, 13032 [05-5334]
Download as PDF
<![CDATA[
13032
Federal Register / Vol. 70, No. 51 / Thursday, March 17, 2005 / Notices
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than March 31, 2005.
A. Federal Reserve Bank of New
York (Jay Bernstein, Bank Supervision
Officer) 33 Liberty Street, New York,
New York 10045-0001:
1. HSH Nordbank, AG, Hamburg,
Germany; to engage de novo through NY
Credit Real Estate Fund, L.P., and New
York Credit Advisors LLC, a joint
venture investment, in extending credit
and servicing loans and acting as an
investment or financial advisor,
pursuant to sections 225.28(b)(1) and
(b)(6) of Regulation Y.
Board of Governors of the Federal Reserve
System, March 11, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–5270 Filed 3–17–05; 8:45 am]
BILLING CODE 6210–01–S
VerDate jul<14>2003
14:51 Mar 16, 2005
Jkt 205001
Agency for Healthcare Research and
Quality
Dated: March 10, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05–5334 Filed 3–16–05; 8:45 am]
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for Partnerships in
Implementing Patient Safety (RFA–HS–
05–012) are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Partnerships in
Implementing Patient Safety.
Date: April 6–8, 2005 (Open on April
6 from 2 p.m. to 3 p.m. and closed for
the remainder of the meeting).
Place: John M. Eisenberg Building,
AHRQ Conference Center, 540 Gaither
Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the nonconfidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Cooperative Agreement With the
Kenya Medical Research Institute
(KEMRI); Notice of Intent To Fund
Single Eligibility Award
A. Purpose
The Centers for Disease Control and
Prevention (CDC) announces the intent
to fund fiscal year (FY) 2005 funds for
a cooperative agreement program to:
1. To conduct field and laboratory
research and implement public health
programs on important human
infectious diseases, with an emphasis
on HIV/AIDS, malaria, emerging and
other emerging and re-emerging
infectious diseases as well as other
identifiable public health problems.
2. To provide training for students
and public health professionals in basic
and applied public health research,
public health program planning,
implementation and evaluation and
other related issues such as data
collection, financial planning and
management.
3. To strengthen the Kenya Medical
Research Institute KEMRI) institutional
capacity to conduct research, plan,
implement and evaluate public health
programs, provide surveillance, and
develop interventions as well as support
national and regional infectious disease
identification and control efforts.
4. To incorporate the results of
research into operational disease
prevention and control programs in the
Republic of Kenya and ensure sharing of
expertise and research findings with
other nations.
The Catalog of Federal Domestic
Assistance number for this program is
93.283.
B. Eligible Applicant
Assistance will be provided only to
KEMRI. No other applications are
solicited. KEMRI is the most appropriate
and qualified agency to conduct the
activities specified under this
cooperative agreement because:
1. KEMRI is the only research
organization in Kenya that possesses the
requisite scientific and technical
expertise, the infrastructure capacity
and who has conducted malaria and
E:\FR\FM\17MRN1.SGM
17MRN1
]]>Agencies
[Federal Register Volume 70, Number 51 (Thursday, March 17, 2005)]
[Notices]
[Page 13032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5334]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for Partnerships in Implementing Patient
Safety (RFA-HS-05-012) are to be reviewed and discussed at this
meeting. These discussions are likely to reveal personal information
concerning individuals associated with the applications. This
information is exempt from mandatory disclosure under the above-cited
statutes.
SEP Meeting on: Partnerships in Implementing Patient Safety.
Date: April 6-8, 2005 (Open on April 6 from 2 p.m. to 3 p.m. and
closed for the remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ Conference Center, 540
Gaither Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone
(301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: March 10, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-5334 Filed 3-16-05; 8:45 am]
BILLING CODE 4160-90-M
